Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16796026 | 0.91 | TP53 (0.41) | TP53KDM4EMAPTGAAHTT | |
| SCHEMBL16287426 | 0.84 | TP53 (0.56) | TP53KDM4EHTTCYP1A2CYP3A4 | |
| SCHEMBL6552201 | 0.84 | TP53 (0.40) | TP53KDM4EMAPTGAAHTT | |
| SCHEMBL7879488 | 0.80 | AKR1C3 (0.57) | KDM4EMAPTGAAHTTCYP2C9 | |
| SCHEMBL18046463 | 0.80 | MAPT (0.37) | MAPTGAACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL2006887 | 0.80 | AKR1C3 (0.57) | KDM4EMAPTGAAHTTCYP2C9 | |
| SCHEMBL18046465 | 0.80 | MAPT (0.37) | MAPTGAACYP1A2CYP3A4CYP2C9 | |
| SCHEMBL7607193 | 0.77 | NFKB1 (0.53) | TP53KDM4EMAPT | |
| SCHEMBL7446722 | 0.75 | ALDH1A1 (0.50) | TP53KDM4EMAPTHTTCYP1A2 | |
| SCHEMBL11565347 | 0.75 | TP53 (0.47) | TP53KDM4EMAPTHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1484051-B1 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | OREAL (FR) | 2013-08-21 | — | — | EP | claimed |
| WO-2012010554-A1 | USE OF COMPOUNDS RESULTING FROM A SUGAR POLYOL OR FROM A DEHYDROGENATED SUGAR POLYOL DERIVATIVE AS A UV-SCREENING AGENT; ANTISUN COMPOSITIONS CONTAINING SAME; AND NOVEL COMPOUNDS | L'OREAL (FR) | 2012-01-26 | — | — | WO | claimed |
| US-7534421-B2 | s-Triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | L'OREAL (FR) | 2009-05-19 | — | — | US | claimed |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | L'OREAL (FR) | 2009-03-19 | — | — | US | claimed |
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | L'OREAL (FR) | 2005-01-13 | — | — | US | claimed |
| US-20040258636-A1 | Novel s-triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2004-12-23 | — | — | US | claimed |
| EP-1466908-A1 | S-tiazin-derivatives having at least one grafted para-aminobenzalmalonic acid salt and sun screening preparations comprising those derivatives | L'OREAL (FR) | 2004-10-13 | — | — | EP | claimed |
| CN-114760982-B | Composition comprising a cationic polysaccharide and an anionic antioxidant | 莱雅公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2024110352-A1 | HYDRATING COMPLEX AND USE IN MOISTURISING COMPOSITIONS | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) | 2024-05-30 | — | — | WO | disclosed |
| WO-2023277194-A1 | SUNSCREEN W/O EMULSION | L'OREAL (FR) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022234092-A1 | Oil-in-water emulsion comprising a particular mixture of surfactants and the combination of at least one starch grafted with an acrylic polymer and of at least one starch not grafted with an acrylic polymer | L'OREAL (FR) | 2022-11-10 | — | — | WO | disclosed |
| EP-4076340-A1 | SUN CARE COMPOSITION | L'OREAL (FR) | 2022-10-26 | — | — | EP | disclosed |
| WO-2012010554-A1 | USE OF COMPOUNDS RESULTING FROM A SUGAR POLYOL OR FROM A DEHYDROGENATED SUGAR POLYOL DERIVATIVE AS A UV-SCREENING AGENT; ANTISUN COMPOSITIONS CONTAINING SAME; AND NOVEL COMPOUNDS | L'OREAL (FR) | 2012-01-26 | — | — | WO | disclosed |
| US-20040258636-A1 | Novel s-triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2004-12-23 | — | — | US | disclosed |
| EP-1484051-A2 | Use of at least one blue-light screening agent to preserve the amount of endogenous carotenoids in the skin, new blue- light screening agents, cosmetic compositions. | L'OREAL (FR) | 2004-12-08 | — | — | EP | disclosed |
| EP-1466908-A1 | S-tiazin-derivatives having at least one grafted para-aminobenzalmalonic acid salt and sun screening preparations comprising those derivatives | L'OREAL (FR) | 2004-10-13 | — | — | EP | disclosed |
| US-6517742-B1 | 2-(butyl 4'-ylaminobenzoate)-4,6-bis((1,3,3,3-tetramethyl-1 -((trimethylsilyl)oxy)disiloxanyl)propyl-3-ylamino)-s-triazine; s-triazine derivatives substituted by at least one silicone group; from cyanuric chloride | L'OREAL (FR) | 2003-02-11 | — | — | US | disclosed |
| EP-0841341-B1 | Sunscreen agents, and cosmetic compositions containing them | OREAL (FR) | 1999-04-07 | — | — | EP | disclosed |
| EP-0841341-A1 | Sunscreen agents, and cosmetic compositions containing them | L'OREAL (FR) | 1998-05-13 | — | — | EP | disclosed |
| EP-0841341-A1 | Sunscreen agents, and cosmetic compositions containing them | L'OREAL (FR) | 1998-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050008588-A1 | Aminoarylvinyl-s-triazine compounds and uses thereof | TYR, AAAS, ALAD | TP53 1686/4885KDM4E 1977/4885MAPT 910/4885 |
| US-20040258636-A1 | Novel s-triazine compounds bearing at least one para-aminobenzalmalonic salt substituent and photoprotective cosmetic compositions comprised thereof | TYR, KRT18, TST | TP53 143/4885KDM4E 497/4885MAPT 1270/4885 |
| US-20090074820-A1 | AMINOARYLVINYL-S-TRIAZINE COMPOUNDS AND USES THEREOF | TYR, AAAS, ALAD | TP53 1661/4885KDM4E 1697/4885MAPT 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.